WAY-326813 is a potent and selective antagonist of the 5-HT6 receptor, primarily used in neuroscience research to study cognitive function and neurodegenerative disorders. It has been investigated for its potential to enhance learning and memory, making it a compound of interest in the development of treatments for Alzheimer's disease and other cognitive impairments. Preclinical studies show that blocking the 5-HT6 receptor can increase neurotransmitter release, such as acetylcholine and glutamate, in brain regions associated with memory and attention. Due to its pharmacological profile, WAY-326813 serves as a valuable tool compound in validating the therapeutic role of 5-HT6 receptor modulation in psychiatric and neurological conditions.